Puma Biotechnology announces presentation of findings from a phase II study of alisertib in…
Ongoing biomarker analysis may help clarify which patients could benefit most from alisertib Puma Biotechnology, announced the…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Puma Biotechnology
Frost & Sullivan releases drug launch and Phase III trial watch list for top therapeutic areas
Oncology, autoimmune and infectious diseases/vaccines are areas for novel therapeutics and in vitro diagnostics in 2015